(VIANEWS) – The Bank of Princeton (BPRN), Summit Financial Group (SMMF), Medpace Holdings (MEDP) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. The Bank of Princeton (BPRN)
20.6% sales growth and 12.15% return on equity
The Bank of Princeton provides various banking products and services. The company accepts checking, savings, attorney trust, and money market accounts, as well as certificates of deposit. Its loan products include commercial real estate and multi-family, commercial and industrial, construction, residential first-lien mortgage, home equity, and consumer loans, as well as lines of credit. The company also provides debit and credit cards; and money orders, direct deposit, automated teller machines, cashier's checks, safe deposit boxes, wire transfers, night depository, remote deposit capture, savings bonds redemption, bank-by-mail, online and automated telephone banking, Internet banking, payroll-related services, and merchant credit card processing services. It operates 21 branches in Princeton, including parts of Mercer, Somerset, Hunterdon, Monmouth, Middlesex, Ocean, Gloucester, Camden, and Burlington counties in New Jersey, and additional areas in portions of Philadelphia, Montgomery, and Bucks counties in Pennsylvania. The Bank of Princeton was founded in 2007 and is headquartered in Princeton, New Jersey.
Earnings Per Share
As for profitability, The Bank of Princeton has a trailing twelve months EPS of $4.11.
PE Ratio
The Bank of Princeton has a trailing twelve months price to earnings ratio of 8.54. Meaning, the purchaser of the share is investing $8.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.15%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Feb 8, 2023, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 3.43%.
Moving Average
The Bank of Princeton’s worth is above its 50-day moving average of $33.58 and way higher than its 200-day moving average of $30.47.
2. Summit Financial Group (SMMF)
20.1% sales growth and 15.61% return on equity
Summit Financial Group, Inc. operates as a financial holding company for Summit Community Bank, Inc. that provides community banking and other financial services to individuals and businesses primarily in the Eastern Panhandle, Southern and North Central regions of West Virginia and the Northern, and Shenandoah Valley and Southwestern regions of Virginia, and the Central region of Kentucky. The company's community banking services include demand, savings, and time deposits; commercial, commercial real estate, construction and land development, residential real estate, and consumer loans; and mortgage warehouse lines of credit, as well as trust and wealth management, cash management, and insurance brokerage services. As of December 31, 2020, it operated through 43 banking offices. The company was incorporated in 1987 and is headquartered in Moorefield, West Virginia.
Earnings Per Share
As for profitability, Summit Financial Group has a trailing twelve months EPS of $4.08.
PE Ratio
Summit Financial Group has a trailing twelve months price to earnings ratio of 6.22. Meaning, the purchaser of the share is investing $6.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.61%.
Moving Average
Summit Financial Group’s worth is higher than its 50-day moving average of $25.36 and under its 200-day moving average of $27.41.
Sales Growth
Summit Financial Group’s sales growth is 16.6% for the ongoing quarter and 20.1% for the next.
3. Medpace Holdings (MEDP)
18.8% sales growth and 36.34% return on equity
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Earnings Per Share
As for profitability, Medpace Holdings has a trailing twelve months EPS of $6.44.
PE Ratio
Medpace Holdings has a trailing twelve months price to earnings ratio of 32.3. Meaning, the purchaser of the share is investing $32.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.34%.
4. SPS Commerce (SPSC)
17.3% sales growth and 10.63% return on equity
SPS Commerce, Inc. provides cloud-based supply chain management solutions worldwide. It offers solutions through the SPS Commerce, a cloud-based platform that enhances the way retailers, suppliers, grocers, distributors, and logistics firms manage and fulfill omnichannel orders, optimize sell-through performance, and automate new trading relationships. The company also provides Fulfillment solution that provides fulfillment automation and replaces or augments an organization's existing staff and trading partner electronic communication infrastructure by enabling easy compliance with retailers' rulebooks, automatic, and digital exchange of information among numerous trading partners through various protocols, and greater visibility into the journey of an order; and Analytics solution, which consists of data analytics applications that enables customers to enhance their visibility across supply chains through greater analytics capabilities. In addition, it offers various complimentary products, such as assortment product, which enables accurate order management and rapid fulfillment; and community product that accelerates vendor onboarding and ensures trading partner adoption of new supply chain requirements. The company was formerly known as St. Paul Software, Inc. and changed its name to SPS Commerce, Inc. in May 2001. SPS Commerce, Inc. was incorporated in 1987 and is headquartered in Minneapolis, Minnesota.
Earnings Per Share
As for profitability, SPS Commerce has a trailing twelve months EPS of $1.28.
PE Ratio
SPS Commerce has a trailing twelve months price to earnings ratio of 115. Meaning, the purchaser of the share is investing $115 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.63%.
Sales Growth
SPS Commerce’s sales growth is 17.3% for the current quarter and 17.3% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17%, now sitting on 431.61M for the twelve trailing months.
Volume
Today’s last reported volume for SPS Commerce is 23804 which is 82.98% below its average volume of 139903.
Previous days news about SPS Commerce(SPSC)
- The zacks analyst blog highlights hirequest, ibex, SPS commerce, diebold nixdorf and inspired entertainment. According to Zacks on Wednesday, 1 March, "(IBEX Quick QuoteIBEX – Free Report) , SPS Commerce Inc. (SPSC Quick QuoteSPSC – Free Report) , Diebold Nixdorf Inc. (DBD Quick QuoteDBD – Free Report) and Inspired Entertainment Inc. (INSE Quick QuoteINSE – Free Report) ."
5. Lattice Semiconductor Corporation (LSCC)
13.6% sales growth and 39.81% return on equity
Lattice Semiconductor Corporation, together with its subsidiaries, develops and sells semiconductor products in Asia, Europe, and the Americas. The company offers field programmable gate arrays that consist of four product families, including the Certus-NX and ECP, MachXO, iCE40, and CrossLink. It also provides video connectivity application specific standard products. In addition, the company licenses its technology portfolio through standard IP and IP core licensing, patent monetization, and IP services. It sells its products directly to end customers, and indirectly through a network of independent manufacturers' representatives and independent distributors. The company primarily serves original equipment manufacturers in the communications and computing, consumer, and industrial and automotive end markets. Lattice Semiconductor Corporation was incorporated in 1983 and is headquartered in Hillsboro, Oregon.
Earnings Per Share
As for profitability, Lattice Semiconductor Corporation has a trailing twelve months EPS of $1.24.
PE Ratio
Lattice Semiconductor Corporation has a trailing twelve months price to earnings ratio of 67.46. Meaning, the purchaser of the share is investing $67.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.81%.
Sales Growth
Lattice Semiconductor Corporation’s sales growth is 19.6% for the current quarter and 13.6% for the next.
6. Kirby Corporation (KEX)
10.8% sales growth and 4.19% return on equity
Kirby Corporation operates domestic tank barges in the United States. Its Marine Transportation segment provides marine transportation services and towing vessels transporting bulk liquid products, as well as operates tank barges throughout the Mississippi River System, on the Gulf Intracoastal Waterway, coastwise along three United States coasts, and in Alaska and Hawaii. This segment also transports petrochemicals, black oil, refined petroleum products, and agricultural chemicals by tank barges; and operates offshore dry-bulk barge and tugboat units that are engaged in the offshore transportation of dry-bulk cargoes in the United States coastal trade. As of December 31, 2019, this segment owned and operated 1,053 inland tank barges with 23.4 million barrels of capacity, 299 inland towboats, 49 coastal tank barges with 4.7 million barrels of capacity, 47 coastal tugboats, 4 offshore dry-bulk cargo barges, 4 offshore tugboats, and 1 docking tugboat. The company's Distribution and Services segment sells replacement parts; provides service mechanics to overhaul and repair engines, transmissions, reduction gears, and related oilfield services equipment; rebuilds component parts or diesel engines, transmissions and reduction gears, and related equipment used in oilfield services, marine, power generation, on-highway, and other industrial applications; rents industrial compressors, railcar movers, and high capacity lift trucks; and manufactures and remanufactures oilfield service equipment, including pressure pumping units. It serves oilfield service, on-highway transportation, marine transportation, commercial fishing, construction, and power generation companies, as well as oil and gas operators and producers, and the United States government. The company was formerly known as Kirby Exploration Company, Inc. and changed its name to Kirby Corporation in 1990. Kirby Corporation was founded in 1921 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Kirby Corporation has a trailing twelve months EPS of $2.01.
PE Ratio
Kirby Corporation has a trailing twelve months price to earnings ratio of 35.37. Meaning, the purchaser of the share is investing $35.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.19%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Kirby Corporation’s EBITDA is 2.04.
Yearly Top and Bottom Value
Kirby Corporation’s stock is valued at $71.09 at 10:22 EST, below its 52-week high of $75.08 and way above its 52-week low of $55.03.
7. Laureate Education (LAUR)
10.5% sales growth and 3.2% return on equity
Laureate Education, Inc., together with its subsidiaries, provides higher education programs and services to students through a network of universities and higher education institutions. It offers a range of undergraduate and graduate degree programs primarily in the areas of business and management, medicine and health sciences, and engineering and information technology through campus-based, online, and hybrid programs. The company provides its services in Brazil, Mexico, Chile, Peru, and the United States. The company was formerly known as Sylvan Learning Systems, Inc. and changed its name to Laureate Education, Inc. in May 2004. The company was founded in 1989 and is headquartered in Baltimore, Maryland.
Earnings Per Share
As for profitability, Laureate Education has a trailing twelve months EPS of $0.1.
PE Ratio
Laureate Education has a trailing twelve months price to earnings ratio of 106.4. Meaning, the purchaser of the share is investing $106.4 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.2%.
Sales Growth
Laureate Education’s sales growth is 12.2% for the current quarter and 10.5% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Laureate Education’s EBITDA is 22.08.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.4%, now sitting on 1.19B for the twelve trailing months.
Moving Average
Laureate Education’s value is higher than its 50-day moving average of $10.22 and below its 200-day moving average of $11.17.
8. Fresenius Medical Care AG (FMS)
9.6% sales growth and 6.66% return on equity
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Earnings Per Share
As for profitability, Fresenius Medical Care AG has a trailing twelve months EPS of $2.39.
PE Ratio
Fresenius Medical Care AG has a trailing twelve months price to earnings ratio of 8.07. Meaning, the purchaser of the share is investing $8.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.66%.
Sales Growth
Fresenius Medical Care AG’s sales growth is 10.1% for the ongoing quarter and 9.6% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 48.9% and a negative 28.6%, respectively.
Volume
Today’s last reported volume for Fresenius Medical Care AG is 93295 which is 88.98% below its average volume of 847188.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.7%, now sitting on 19.05B for the twelve trailing months.
